Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
GZPHF
$2.34
$0.000.00%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 10.71B | 10.47B | 10.29B | 10.40B | 10.58B |
| Total Other Revenue | 29.62M | 32.46M | 29.63M | 29.63M | 33.15M |
| Total Revenue | 10.74B | 10.50B | 10.32B | 10.43B | 10.61B |
| Cost of Revenue | 8.96B | 8.79B | 8.66B | 8.69B | 8.82B |
| Gross Profit | 1.78B | 1.71B | 1.66B | 1.73B | 1.80B |
| SG&A Expenses | 1.15B | 1.11B | 1.07B | 1.12B | 1.11B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 33.16M | 43.76M | 32.56M | 24.36M | -3.54M |
| Total Operating Expenses | 10.23B | 10.04B | 9.86B | 9.94B | 10.03B |
| Operating Income | 512.57M | 460.88M | 455.96M | 483.45M | 578.11M |
| Income Before Tax | 522.99M | 478.67M | 467.12M | 501.98M | 606.97M |
| Income Tax Expenses | 93.52M | 77.27M | 77.22M | 84.45M | 103.51M |
| Earnings from Continuing Operations | 429.47 | 401.40 | 389.90 | 417.53 | 503.46 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -17.02M | -14.75M | -17.67M | -22.96M | -27.29M |
| Net Income | 412.44M | 386.65M | 372.23M | 394.58M | 476.17M |
| EBIT | 512.57M | 460.88M | 455.96M | 483.45M | 578.11M |
| EBITDA | 595.81M | 546.60M | 542.93M | 573.16M | 670.20M |
| EPS Basic | 0.25 | 0.24 | 0.23 | 0.24 | 0.29 |
| Normalized Basic EPS | 0.20 | 0.17 | 0.18 | 0.19 | 0.21 |
| EPS Diluted | 0.25 | 0.24 | 0.23 | 0.24 | 0.29 |
| Normalized Diluted EPS | 0.20 | 0.17 | 0.18 | 0.19 | 0.21 |
| Average Basic Shares Outstanding | 6.50B | 6.50B | 6.50B | 6.50B | 6.50B |
| Average Diluted Shares Outstanding | 6.50B | 6.50B | 6.50B | 6.50B | 6.50B |
| Dividend Per Share | 0.11 | 0.11 | 0.11 | 0.11 | 0.16 |
| Payout Ratio | 79.53% | 65.99% | 86.57% | 81.46% | 48.34% |